Premature Ejaculation Clinical Trial
Official title:
A Randomized, Controlled Study of the Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device
Verified date | July 2018 |
Source | Instituto Sexológico Murciano |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The present study included 57 patients ≥18 years who met diagnostic criteria for PE including
intravaginal ejaculatory latency time (IELT) of ≤2 minutes and had a Premature Ejaculation
Diagnostic Tool (PEDT) score ≥11.
Subjects were randomized to an experimental group that used the device with exercise
programme (n=18) a first control group that only used the exercise programme (n=17) and a
wait-list control group (n=22).
As a main outcome measure used stopwatch-measured average IELT, Premature Ejaculation Profile
(PEP), and the Golombok-Rust Inventory of Sexual Satisfaction (GRISS).
Status | Completed |
Enrollment | 35 |
Est. completion date | December 1, 2017 |
Est. primary completion date | October 30, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Participants must be heterosexual males - To be in a stable monogamous, sexual relationship with a female partner for at least 6 months, - Must score = 11 in the Premature Ejaculation Diagnostic Tool (PEDT). - Must have a self-estimated average intravaginal ejaculatory latency time (IELT) of <2 min. -Must be in good general health with no clinically significant abnormalities as determined by medical history and clinical lab results. Exclusion Criteria: - To suffer an alteration or mental disorder according to the criteria of the DSM-IV. - History of alcohol abuse and dependence. - Do not to consume medication, drugs of recreative use or alcohol (except for caffeine or nicotine/tobacco). |
Country | Name | City | State |
---|---|---|---|
Spain | Jesús Rodríguez | Murcia |
Lead Sponsor | Collaborator |
---|---|
Instituto Sexológico Murciano | Universidad Miguel Hernandez de Elche |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Golombok Rust Inventory of Sexual Satisfaction (GRISS) | Scale ejaculatory function | 7 weeks | |
Primary | IELT FOLD INCREASE | fold changes are defined directly in terms of ratios.If the initial value is A and the final value B, the fold change is defined as B/A | 7 weeks | |
Secondary | Premature Ejaculation Profile (PEP) | proportion of patients who achieved criteria for clinical benefit, defined as achieving a two-category or greater increase in the change in control over ejaculation and level of satisfaction with intercourse, and a one-category or greater increase in the change in ejaculation-related distress and degree of interpersonal difficulty. | 7 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02232425 -
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
|
Phase 2 | |
Completed |
NCT01439984 -
Trial of PED-1 in Male Patients With Premature Ejaculation
|
Phase 3 | |
Completed |
NCT01203202 -
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
|
Phase 2 | |
Completed |
NCT01184105 -
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
|
Phase 1 | |
Completed |
NCT03942367 -
Evaluation of the Safety and Effectiveness of the vPatch Device
|
N/A | |
Recruiting |
NCT06425211 -
Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
|
N/A | |
Completed |
NCT02939495 -
The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy
|
Phase 4 | |
Completed |
NCT02572037 -
Research and Clinical Value of New Classification for Premature Ejaculation: Multi-Center Research
|
||
Recruiting |
NCT02581826 -
Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation
|
Phase 2 | |
Terminated |
NCT00983736 -
Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
|
Phase 3 | |
Completed |
NCT00549211 -
A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.
|
Phase 1 | |
Completed |
NCT00556478 -
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05556083 -
Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)
|
Phase 2 | |
Completed |
NCT00861484 -
Proof of Mechanism in ELT
|
Phase 1 | |
Completed |
NCT02984592 -
Effect of Exercise on Premature Ejaculation
|
N/A | |
Recruiting |
NCT02571101 -
A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation
|
Phase 2 | |
Completed |
NCT03174470 -
Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle
|
N/A | |
Completed |
NCT02794454 -
A Study to Evaluate Efficacy of Investigational Product HeezOn Ultra -1/ HeezOn Ultra-2 on Male Sexual Health
|
N/A | |
Completed |
NCT02297152 -
A New Treatment for Premature Ejaculation?
|
N/A | |
Not yet recruiting |
NCT00656552 -
Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
|
Phase 0 |